Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.23 - $160.0 $2 - $1,600
10 Added 0.02%
45,010 $8,000
Q3 2021

Nov 08, 2021

BUY
$1.06 - $1.52 $5,300 - $7,600
5,000 Added 12.5%
45,000 $48,000
Q2 2021

Aug 09, 2021

BUY
$1.22 - $1.65 $6,100 - $8,250
5,000 Added 14.29%
40,000 $60,000
Q1 2021

May 12, 2021

BUY
$1.18 - $2.62 $23,600 - $52,400
20,000 Added 133.33%
35,000 $54,000
Q4 2020

Feb 16, 2021

BUY
$1.05 - $2.24 $15,750 - $33,600
15,000 New
15,000 $16,000

About iBio, Inc.


  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $23.8M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track Inter Ocean Capital Group, LLC Portfolio

Follow Inter Ocean Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inter Ocean Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inter Ocean Capital Group, LLC with notifications on news.